Quarterly Activities/Appendix 4C Cash Flow Report

Open PDF
Stock Adisyn Ltd (AI1.ASX)
Release Time 30 Oct 2025, 8:13 a.m.
Price Sensitive Yes
 Adisyn reports quarterly progress in graphene R&D
Key Points
  • Company retains strong balance sheet with A$6.0 million in cash
  • Major facility upgrade completed and Beneq TFS 200 ALD system installed and commissioned
  • Dual ALD-based graphene R&D activities underway at 2DG and Tel Aviv University
Full Summary

Adisyn Ltd (ASX: AI1) has provided its Quarterly Activities and Cash Flow Report for the period ending 30 September 2025, during which the Company made significant advancements in developing its revolutionary graphene-based technology. The Company announced the successful installation, commissioning and calibration of its newly acquired Beneq TFS 200 Atomic Layer Deposition (ALD) system, completed by wholly owned subsidiary, 2D Generation ('2DG'). This system is now operating in tandem with a similar system located at Tel Aviv University's Jan Koum Center for Nanoscience and Nanotechnology, allowing 2DG to run concurrent testing and accelerate the validation of graphene films across various substrates, layer structures and operating conditions. The commissioning follows the successful completion of a substantial infrastructure upgrade at the 2D Generation facility. The Company has commenced the next critical phase of graphene development, focused on precursor development and graphene growth. This includes plasma pre-clean, deposition sequence, post-anneal, and rigorous characterisation and feedback to optimise growth parameters. Adisyn believes this low-temperature ALD graphene growth process, if scalable and repeatable, has the potential to unlock a new generation of semiconductor interconnects. The Company will continue to provide regular updates as development milestones are achieved.